Last $69.86 USD
Change Today +0.02 / 0.03%
Volume 2.0M
COV On Other Exchanges
Symbol
Exchange
New York
Frankfurt
As of 8:04 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

covidien plc (COV) Key Developments

Covidien plc Announces U.S. Food and Drug Administration 510(K) Clearance for the Kangaroo(TM) Feeding Tube with IRIS Technology

Covidien plc announced U.S. Food and Drug Administration 510(k) Clearance for the Kangaroo(TM) feeding tube with IRIS Technology. This camera-equipped disposable feeding tube is designed to enhance patient safety by providing visualization for a procedure that is currently blinded. The Covidien Integrated Real-time Imaging System (IRIS) technology streams a real-time video back to the Kangaroo IRIS monitor, providing visual information that can aid clinicians in identifying key areas of a patient's anatomy. The Covidien Integrated Real-time Imaging System (IRIS) technology streams a real-time video back to the Kangaroo IRIS monitor, providing visual information that can aid clinicians in identifying key areas of a patient's anatomy. The system also enables medical professionals to save images from the live stream and make notes associated with the image. Prior to availability of the Kangaroo feeding tube with IRIS technology, feeding tube placement was often done blindly. The risk associated with blind placement is the misplacement of the feeding tube into the patient's airway, which can potentially cause a punctured lung or even death. The Kangaroo feeding tube with IRIS technology now gives sight where medical professionals were previously blind. In addition to FDA clearance in the U.S., the Kangaroo feeding tube with IRIS technology is approved for use in Europe, Japan, Canada and Australia. The Kangaroo IRIS monitor is currently programmed with seven languages: English, Spanish, French, German, Italian, Portuguese and Dutch.

Covidien plc Declares Quarterly Cash Dividend, Payable on May 5, 2014

Covidien plc has declared a quarterly cash dividend of $0.32 per ordinary share. The dividend is payable on May 5, 2014, to shareholders of record on April 7, 2014.

Covidien plc Presents at Boston Biotech BD Boston Conference, Mar-25-2014 12:30 PM

Covidien plc Presents at Boston Biotech BD Boston Conference, Mar-25-2014 12:30 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: James C. Clemmer, Senior Vice President and President of Medical Supplies.

Covidien plc Launches Symbotex(TM) Composite Mesh for Surgical Laparoscopic and Open Ventral Hernia Repair

Covidien plc announced the U.S. launch of Symbotex(TM) composite mesh, an innovative product designed to make it easier for surgeons to perform surgical laparoscopic and open ventral hernia repairs. Symbotex(TM) composite mesh for surgical laparoscopic and open ventral hernia repair is designed to offer patients optimal hernia repair performance. A ventral hernia can develop when the outer layers of the abdominal wall weaken, bulge or tear, with most hernias resulting from strain on the abdominal muscles. Hernias can grow larger over time and cause serious complications if not surgically repaired. Comprising a macroporous monofilament, hydrophilic textile in a three-dimensional construction that allows for reinforced strength, memory shape and significant tissue ingrowth. A bioabsorbable collagen film on the visceral side minimizes tissue attachments. Symbotex mesh offers surgeons improved ease of use with an orientation marker that facilitates correctly placing the mesh over the hernia defect. Additionally, Symbotex mesh is transparent, offering improvements to the visualization of the anatomy during mesh placement and fixation. Symbotex composite mesh is available in a variety of shapes and sizes for laparoscopic and open ventral hernia repair.

Covidien plc Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-13-2014 10:45 AM

Covidien plc Presents at Barclays Capital 2014 Global Healthcare Conference, Mar-13-2014 10:45 AM. Venue: Loews Miami Beach Hotel, Miami, Florida, United States. Speakers: Charles J. Dockendorff, Chief Financial Officer and Executive Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
COV:US $69.86 USD +0.02

COV Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Actavis plc $197.39 USD -1.99
Baxter International Inc $72.81 USD -0.64
Becton Dickinson and Co $113.16 USD +0.23
Stryker Corp $78.78 USD -0.27
Tyco International Ltd $42.22 USD +0.66
View Industry Companies
 

Industry Analysis

COV

Industry Average

Valuation COV Industry Range
Price/Earnings 21.1x
Price/Sales 3.1x
Price/Book 3.3x
Price/Cash Flow 19.6x
TEV/Sales 2.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact COVIDIEN PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.